Urologic, An issue of Salvage Therapies for Non-Muscle Invasive Bladder Cancer
Seiten
2019
Elsevier - Health Sciences Division (Verlag)
978-0-323-72256-8 (ISBN)
Elsevier - Health Sciences Division (Verlag)
978-0-323-72256-8 (ISBN)
Together with Consulting Editor Dr. Samir Taneja, Dr. Badrinath Konety has put together a comprehensive issue that addresses Salvage therapies for Non-Muscle Invasive Bladder Cancer. Expert authors have contributed clinical review articles on the following topics: BCG salvage therapy: Definition and context; Who will respond to BCG? Predictors and nomograms; Identification of candidates for salvage therapy: Definition of BCG "Failure; Predictors of response to Intravesical therapy; Precision medicine for NMIBC; Salvage therapy using BCG derivatives or single agent chemotherapy; Intravesical heated Mitomycin: Biology and clinical utility; Mitomycin derivatives in the salvage setting; Combination intravesical therapy; Intravesical gene therapy; Immunoncology as salvage therapy; Role of IDO inhibitors in salvage therapy; and Novel agents for intravesical therapy. Readers will come away with the clinical information they need to improve outcomes in patients with bladder cancer.
| Erscheinungsdatum | 10.12.2019 |
|---|---|
| Reihe/Serie | The Clinics: Surgery |
| Verlagsort | Philadelphia |
| Sprache | englisch |
| Gewicht | 450 g |
| Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Urologie |
| ISBN-10 | 0-323-72256-3 / 0323722563 |
| ISBN-13 | 978-0-323-72256-8 / 9780323722568 |
| Zustand | Neuware |
| Informationen gemäß Produktsicherheitsverordnung (GPSR) | |
| Haben Sie eine Frage zum Produkt? |
Mehr entdecken
aus dem Bereich
aus dem Bereich
Harninkontinenz und Erektionsstörungen mindern und überwinden
Buch | Softcover (2025)
Urban & Fischer in Elsevier (Verlag)
CHF 39,20
